Member
Providers
Shop For a Plan

Ambetter-from-Fidelis-Care-logo

Site of Care

For Ambetter from Fidelis Care Qualified Health Plan Patients

Site of Care Optimization: Delivering Value Across the System

Our Site of Care program supports evidence-based transitions for Ambetter from Fidelis Care Qualified Health Plan patients receiving infusion or specialty therapies in high-cost settings, such as hospitals. The goal is to transition eligible patients to clinically appropriate lower-cost alternatives – like home infusion or freestanding infusion centers – when suitable. By aligning with clinical best practices, we help ensure appropriate care delivery in lower-cost, high-quality environments.


Why This Matters

  • Improved Patient Experience 
    Patients often prefer care closer to home or in lower-acuity settings, with greater comfort and convenience. 
  • Reduced Total Cost of Care 
    Shifting treatment to lower-cost sites may help reduce drug administration costs while maintaining high clinical standards. 
  • Streamlined Referrals 
    We offer support for identifying qualified alternative sites and facilitating transitions, minimizing administrative burden. 
  • Better Clinical Alignment 
    This approach reflects industry best practices, payer expectations, and value-based care models. 


How You Can Help

  • Refer patients to in-network, lower-cost infusion sites when appropriate 
  • Engage with our team if you have questions about eligibility or need help with referrals 
  • Educate patients on their options and benefits of optimized site placement  
  • Share feedback on operational or clinical considerations to improve program success 

Together, we can enhance patient care while reducing healthcare costs across the system.


Prescriber Quick Reference Guide

The medications listed below are included in the Pilot Site of Care (SOC) Program. For a comprehensive list of specialty medications that may be eligible for home or alternate site infusion, please refer to the full Site of Care Policy NY.CP.PHAR.493.

Commonly Prescribed Medications by Condition

Condition

Medications

Autoimmune Disorders

AVSOLA

REMICADE

ENTYVIO

RENFLEXIS

INFLECTRA

Multiple Sclerosis

OCREVUS

TYSABRI

Paroxysmal Nocturnal Hemoglobinuria

BKEMY

SOLIRIS

ENTYVIO

EPYSQLI

ULTOMIRIS

Gonadotropin-Releasing Hormone Agonist

ELIGARD

LUPRON

LUPRON DEPOT

Transplant

NULOJIX

Thyroid Eye Disease

TEPEZZA

Inflammatory Conditions

SKYRIZI

Enzyme Deficiencies

FABRAZYME

NEXVIAZYME

Immune Deficiencies & Related Disorders

GAMMAGARD LUQUID

OCTAGAM

GAMMAKED

PRIVIGEN

Miscellaneous Diseases

VYVGART

Home Infusion Services Offer: 

🕒 Convenience 
Infusions administered in the home or at an Ambulatory Infusion Suite (AIS) are scheduled directly with patients—providing flexibility, independence, and improved quality of life. 

💰 Cost Savings 
Home or AIS infusions are often lower in cost for patients, which may improve adherence to therapy, enhance outcomes, and reduce overall healthcare expenditures. 

🩺 Safety 

Infusion clinicians are specially trained and certified in administering complex drug therapies and in monitoring patients to ensure safe and effective care. 

For Referrals or More Information  

 Utilization Management Site of Care Team 
📞 866-861-6269  
✉️ Email: CPS_UM_SOC@centene.com 
🕗 Monday–Friday, 8:00 a.m. – 5:00 p.m. (ET) 
Please reference the Site of Care Program when contacting our team. 

It is the policy of health plans affiliated with Centene Corporation that requests for outpatient IV or injectable therapy not meeting specific criteria may be redirected to a less intensive, alternate site of care. (Policy: NY.CP.PHAR.493).

 

Infusion Provider Options for Site of Care

Provider Name

Services Offered

Phone Number

Fax Number

Website

Acaria Health

Home

800-511-5144

877-541-1503

https://www.acariahealth.com/

Option Care

Home or AIS

718-961-1634

718-762-8741

https://optioncarehealth.com/

Soleo Health

Home or AIS

800-395-6143

800-395-6149

https://www.soleohealth.com/

Prime Infusion

Home

718-443-4000

718-443-5000

https://primeinfusions.com/

CNY Infusions

Home

315-424-7027

315-424-7638

https://cnyinfusion.com/

Coram

Home or AIS

866-899-1661

866-843-3221

https://www.coramhc.com/providers

Accredo
*12/01

Home

844-581-4862

https://www.accredo.com/

Optum

Home or AIS

800-346-6348

631-391-9670

877-342-9352

866-689-3569

888-594-4844

https://www.optum.com/en/pharmacy-services/infusion-pharmacy.html

Kaba Fusion

Home

800-238-2247

877-234-6400

518-862-1400

315-469-9744

https://www.kabafusion.com/


-Nursing services available for all listed above.

-This list is not exhaustive, and additional vendors may be considered, provided they hold an active contract within the State of New York.


Site of Care Optimization Program – Frequently Asked Questions (FAQs)

Key Terms 

  • Site of Care (SOC): The physical location where a patient receives infusion therapy. Common sites include hospital outpatient departments (HOPDs), physician offices, home infusion services, or ambulatory infusion suites (AIS). 
  • Ambulatory Infusion Suite (AIS): A non-hospital outpatient clinic specifically designed for administering infusion therapies.   
What is the Site of Care (SOC) Program?
The SOC Program identifies patients receiving specialty or infusion therapy in high-cost settings (e.g., hospital outpatient departments) and evaluates whether they may be safely transitioned to clinically appropriate, lower-cost alternatives, such as home infusion or freestanding infusion centers. 
Why is this program being implemented?
The goal is to improve patient experience, reduce total cost of care, and support alignment with value-based care models and payer policies. Many infusions administered in hospitals can be safely delivered in alternative settings at significantly lower cost without compromising quality. 
What are examples of alternative sites of care?
  • Home Infusion 
  • Ambulatory Infusion Suites (AIS) 
  • Physician Offices 
Is the SOC program guided by a clinical policy?
Yes. This program is based on Centene Clinical Policy: Infusion Therapy Site of Care Optimization NY.CP.PHAR.493which outlines appropriate criteria for site of care decisions and drugs eligible for redirection. 
What types of therapies or patients are targeted?
The program focuses on select high-cost specialty and infusion drugs where alternative sites of care are safe and effective. Eligibility is determined based on clinical criteria, treatment regimen, benefit design, and geographic access to alternate sites. 
How are patients selected?
Patients are identified through claims data, clinical profiles, and coordination with prescribers. Our team will engage with you before outreach to the patient begins, to ensure clinical appropriateness and continuity of care. 
Is participation in the SOC program mandatory? Are there any exceptions?

Yes, participation is required when clinically appropriate and supported by policy. IF a patient qualified for redirection under the Centene Clinical Policy NY.CP.PHAR.493, transitioning to an alternative site of care is expected.  

However, we understand that every patient’s situation is unique, and exception may apply.  Our Site of Care team carefully reviews each case.  If an exception is warranted, it will be evaluated in accordance with the policy criteria.  Providers will be notified when redirection applies to a patient and will be consulted throughout the process to ensure continuity and quality of care.   

What if my patient is hesitant to switch infusion sites?
It’s not uncommon for patients to have questions or concerns about changing their treatment location.  As a provider, you play a key role in helping them understand that the alternative site offers the same clinical quality.  Our Site of Care team is available to support both you and your patient during the transition.  
What is expected from prescribers?

We ask for your partnership in: 

  • Reviewing patient eligibility 
  • Supporting transitions when appropriate 
  • Prescribing to preferred infusion providers if applicable 
  • Maintaining communication to ensure seamless care delivery 

Additionally, when submitting a prior authorization (PA) request, please indicate the intended site of care.  This helps streamline the process, reduce administrative burden, and avoid follow-up requests. Our Site of Care team is available to assist in identifying nearby, clinically appropriate infusion sites that meet policy and patient needs.  

Will this disrupt patient care?
No. Transitions are coordinated carefully with prescribers, patients, and infusion providers. The same medications and dosing regimens are maintained. Only the site of administration changes, when clinically safe and approved. 
What are the benefits to the patients?

The Site of Care program is designed with the patient in mind – offering meaningful advantages that support both quality and experience of care: 

  • Lower Out-Of-Pocket Costs: Alternative sites may come with reduced patient cost-sharing. Lower costs can improve adherence to treatment, leading to better clinical outcomes 
  • Greater Convenience & Flexibility: Appointments at alternate sites can be scheduled around the patient’s lifestyle – including options for evenings or weekend visits – minimizing disruption to work, school, or family responsibilities. 
  • Reduced Time Commitment & Hospital Exposure: Alternative sites typically offer faster check-in, shorter wait times, and lower risk of hospital-related infection exposure, making the overall experience safer and more efficient.  
  • Improved Patient Satisfaction: Patients redirected to alternate sites consistently report higher satisfaction levels, citing increased comfort, reduced stress, and more personalized care experience. 
Who can I contact for more information?

If you have questions about the Site of Care program or need support with a specific patient case, our Utilization Management Site of Care team is here to help.   

📞 866-861-6269 
📧 CPS_UM_SOC@centene.com 

We’re available to assist with eligibility reviews, site referrals, prior authorizations, and any other program-related inquiries.